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Onchocerciasis and lymphatic filariasis are targeted for elimination, primarily using mass
drug administration at the country and community levels. Elimination of transmission is the
onchocerciasis target and global elimination as a public health problem is the end point for
lymphatic filariasis. Where program duration, treatment coverage, and compliance are
sufficiently high, elimination is achievable for both parasites within defined geographic
areas. However, transmission has re-emerged after apparent elimination in some areas,
and in others has continued despite years of mass drug treatment. A critical question is
whether this re-emergence and/or persistence of transmission is due to persistence of
local parasites—i.e., the result of insufficient duration or drug coverage, poor parasite
response to the drugs, or inadequate methods of assessment and/or criteria for
determining when to stop treatment—or due to re-introduction of parasites via human
or vector movement from another endemic area. We review recent genetics-based
research exploring these questions in Onchocerca volvulus, the filarial nematode that
causes onchocerciasis, and Wuchereria bancrofti, the major pathogen for lymphatic
filariasis. We focus in particular on the combination of genomic epidemiology and
genome-wide associations to delineate transmission zones and distinguish between
local and introduced parasites as the source of resurgence or continuing transmission,
and to identify genetic markers associated with parasite response to chemotherapy. Our
ultimate goal is to assist elimination efforts by developing easy-to-use tools that
incorporate genetic information about transmission and drug response for more
effective mass drug distribution, surveillance strategies, and decisions on when to stop
interventions to improve sustainability of elimination.
Keywords: population genomics, onchocerciasis, lymphatic filariasis, transmission, parasite elimination, drug
resistance, epidemiologyJanuary 2020 | Volume 10 | Article 12821
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Onchocerciasis and lymphatic filariasis (LF) are targeted for
elimination, primarily using community-wide mass drug
administration (MDA). In April 2019, the World Health
Organization (WHO) initiated a global consultation on the
“Roadmap for Neglected Tropical Diseases,” including current
targets for global elimination of LF as a public health problem by
2020 (World Health Organozation, 2012a) and elimination of
transmission of the parasite that causes onchocerciasis in 80% of
affected sub-Saharan countries by 2025 (African Programme for
Onchocerciasis Control, 2012). Barriers to elimination include
operational challenges for adequate drug distribution or non-
compliance leading to low treatment coverage (Churcher et al.,
2009; Turner et al., 2013; African Programme for Onchocerciasis
Control, 2015), movement of humans or vectors among
communities (De Sole et al., 1991; African Programme for
Onchocerciasis Control and World Health Organization, 2010;
Ramaiah, 2013; Xu et al., 2018b; Delineating Transmission Zones
for Sustainable Onchocerciasis and LF Elimination), and
challenges in determining when the transmission cycle has
been interrupted and treatment can be stopped (Stolk et al.,
2015; Lont et al., 2017; Walker et al., 2017). Elimination of these
diseases has been formally verified or validated by the WHO in
some geographic regions, and is under assessment in others
(Parasite Transmission, Morbidity, and Control/Elimination
Strategies). However, there are areas where transmission has
re-emerged after apparent (though not WHO-certified)
elimination, and others where transmission has continued
despite decades of MDA. A critical question is whether “local”
parasites continue to persist because of insufficient MDA
coverage and/or duration relative to the pre-intervention
endemicity, poor parasite drug response, or inadequate
methods of assessment and/or criteria for decisions to stop
treatment, or whether “immigrant” parasites have been
introduced via human or vector movement from another
endemic area. Population genetic analyses of parasite DNA
sequences may provide data to answer this question. With theFrontiers in Genetics | www.frontiersin.org 2increasing technical feasibility of gathering population-level
genomic data, it becomes possible to develop tools allowing
routine acquisition of such data by elimination programs to
inform decisions on MDA strategies, delineate areas to be
included in evaluations, and determine whether treatment
should be continued or stopped.
Parasite Transmission, Morbidity, and
Control/Elimination Strategies
Onchocerciasis
Onchocerca volvulus is transmitted by blackflies of the genus
Simulium. Female blackflies taking a blood meal from an infected
person ingest O. volvulus microfilariae, which develop into
infective L3 larvae that are transmitted to a different host
during subsequent blood meals (Figure 1A). The L3 larvae
develop via L4 into adult worms, macrofilariae, which live for
around 12–14 years in nodules under the skin and deep in the
body, producing millions of microfilariae. The microfilariae
migrate through the skin, eyes, and other organs, and live for
up to 2 years. The immunological reactions upon death of
microfilariae are the major cause of morbidity: primarily
itching, skin depigmentation and lesions, and visual
impairment that can progress to blindness (Remme et al.,
2017). Increasing evidence suggests that high O. volvulus
infection can induce epilepsy (Chesnais et al., 2018).
The pattern of onchocerciasis endemicity is determined by
ecological conditions favorable for Simulium breeding sites,
whose location and productivity (i.e., number of blackflies
hatching) can vary seasonally and from year to year. Simulium
damnosum sensu lato (s.l.), the main vector in Africa, breeds in
fast-flowing rivers and streams with the high level of oxygenation
needed for larval development. The flies typically have an active
flight range of around 15 km, but can migrate seasonally over
hundreds of kilometers if assisted by prevailing winds, and thus
transmit the parasite over large geographic ranges (Garms et al.,
1979; Le Berre et al., 1979; Baker et al., 1990). Infection rates are
highest among those living and/or working close to consistently
highly productive breeding sites and decline with increasingFIGURE 1 | Life cycles of (A) Onchocerca volvulus and (B) Wuchereria bancrofti. From Centers for Disease Control and Prevention (accessed April 2019, https://
www.cdc.gov/dpdx/az.html).January 2020 | Volume 10 | Article 1282
Hedtke et al. Genomics and Filarial Nematode Eliminationdistance between where blackflies breed and where people live
and work.
The morbidity and socio-economic impact of onchocerciasis
motivated three control programs. The Onchocerciasis Control
Programme in West Africa (OCP, 1974–2002) targeted
elimination as a public health problem through weekly aerial
larviciding of breeding sites along ~50,000 km of rivers for the
life span of macrofilariae, later complemented in some areas by
mass drug administration of ivermectin (MDAi). The OCP
originally covered ~654,000 km2, which was expanded to
1,300,000 km2 because Simulium from outside invaded the
original area (Le Berre et al., 1979; Baker et al., 1990; Remme,
2004; Boatin, 2008).
The 1987 decision of Merck & Co., Inc. (Kenilworth, NJ,
USA) to donate ivermectin (Mectizan®) for onchocerciasis
control, and subsequent studies showing the safety of MDAi,
allowed initiation of MDAi-based control programs. The
Onchocerciasis Elimination Program for the Americas (OEPA)
was initiated in 1993 to eliminate transmission in 13 generally
small foci across six countries with a total at-risk population of
0.56 million. Building on early efforts to control onchocerciasis
through nodulectomy campaigns and annual ivermectin
treatments, the OEPA implemented health system–directed
biannual MDAi (and even quarterly MDAi in four areas in
Brazil, Mexico, and Venezuela). Elimination was certified by
WHO for all but the large Amazonian area across the border
between Brazil and Venezuela, where difficult terrain and lack
of roads make it challenging to ensure ivermectin distribution
to ~30,500 Yanomami across ~540 migratory communities
(Sauerbrey et al., 2018; World Health Organization, 2018;
Figure 2).
The APOC (1995–2015) initially targeted control of
onchocerciasis as a public health problem in Central and East
Africa and Liberia with sustainable, community-directedFrontiers in Genetics | www.frontiersin.org 3ivermectin treatment (CDTI). Across the 19 APOC countries,
~86 million people were estimated to require CDTI because they
lived in meso- and hyperendemic areas, i.e., where 20–40% and
>40% of adults, respectively, have subcutaneous nodules (Noma
et al., 2014; Figure 3). These nodule prevalences correspond to
prevalences of skin microfilariae in the general population of
around 40–60% for mesoendemic and >60% for hyperendemic
areas associated with an increased risk of onchocercal blindness
(Prost et al., 1979; UNDP/World Bank/WHO Special
Programme for Research and Training in Tropical Diseases,
1992; Noma et al., 2002; Seketeli, 2002; Seketeli et al., 2002; Fobi
et al., 2015). The sizes of these areas range from relatively small
to a vast contiguous endemic area of ~2 million km2 across seven
countries (Noma et al., 2014; World Health Organization, 2018).
Research and subsequent epidemiological evaluations of
infection rates in areas with long-term MDAi (Diawara et al.,
2009; Traore et al., 2012; Tekle et al., 2016) suggested that MDAi
alone could achieve elimination of transmission in Africa. The
APOC objectives were consequently expanded to onchocerciasis
elimination in at least 80% of African countries by 2025 (African
Programme Onchocerciasis Control, 2012). In 2015, APOC was
closed. The Expanded Special Project for Elimination of
Neglected Tropical Diseases (ESPEN) now provides countries
with some of the support previously provided by APOC.
MDAi in meso- or hyperendemic areas may have reduced
infection prevalence in neighboring hypoendemic areas.
Previously unmapped hypoendemic areas that might impact
elimination goals (Rebollo et al., 2018) by acting as a potential
source of renewed transmission need to be efficiently determined
and cost-effective intervention strategies implemented in these
areas (and those previously identified as hypoendemic and not
included in CDTI). Including the population in hypoendemic
areas mapped by 2017–2018, WHO estimated that 204 million
people required MDAi to achieve elimination (World HealthFIGURE 2 | Global distribution and treatment of lymphatic filariasis (2018) and onchocerciasis (2017), based on WHO Global Health Observatory data repository
(accessed April 2019, https://www.who.int/gho/en/).January 2020 | Volume 10 | Article 1282
Hedtke et al. Genomics and Filarial Nematode EliminationOrganization, 2018). In Central Africa where another filarial
parasite, Loa loa, is endemic, areas previously identified as
requiring interventions based on parasites observed in the skin
may require remapping. Recent data suggest that L. loa
microfilariae, once assumed to be present only in blood, may
also be present in the skin and mistaken for O. volvulus (Nana-
Djeunga et al., 2019).
The OCP experience (Remme et al., 1995) informed the 2001
WHO procedures for entomological assessments and criteria for
certification of onchocerciasis elimination (World Health
Organization, 2001). Those procedures stipulated testing at
least 10,000 flies from each endemic community selected for
evaluation by the WHO International Certification Team,
maximizing the chances of detecting infected flies by collecting
during peak transmission season. In 2010, APOC outlined a
“Conceptual Framework of Onchocerciasis Elimination with
Ivermectin Treatment” which built on the OCP and APOC
experience, took into account differences between control via
vector elimination and via ivermectin treatment, and
emphasized that much is still to be learned (African
Programme for Onchocerciasis Control/World Health
Organization, 2010; Dadzie et al., 2018). This frameworkFrontiers in Genetics | www.frontiersin.org 4defined elimination as “reduction of infection and transmission
to the extent that interventions can be stopped but post-
intervention surveillance is still necessary” and a transmission
zone as a “geographical area where transmission of O. volvulus
occurs by locally breeding vectors and which can be regarded as a
natural ecological and epidemiological unit for interventions.” It
identified delineating transmission zones and examining risks of
parasite reintroduction through human or vector migration as
critical to decisions to stop MDA. Acknowledging that “in
practice it is difficult to determine with a fair degree of
certainty that vectors in a given area are exclusively locally
breeding,” the framework recommended an operational
definition of a transmission zone as a “river basin, or a major
section of a river basin, where onchocerciasis is endemic and
where the river is the core of the endemic area, with communities
with the highest prevalence of infection generally located close to
the river and infection levels falling with increasing distance from
the river until they become negligible or reach a neighboring
transmission zone.” In 2016, theWHO issued a new guideline for
stopping MDA and verifying elimination of human
onchocerciasis (World Health Organization, 2016). This
guideline defines interruption of transmission of O. volvulus asFIGURE 3 | Rapid epidemiological mapping of onchocerciasis (REMO), based on prevalence of nodules across communities with a history of onchocerciasis and
covered by the African Programme for Onchocerciasis Control (APOC). Figure from Zouré et al., (2014).January 2020 | Volume 10 | Article 1282
Hedtke et al. Genomics and Filarial Nematode Elimination“the permanent reduction of transmission in a defined
geographical area after all the adult worms (and microfilariae)
in the human population in that area have died, been
exterminated by some other intervention, or become sterile
and infertile.” While this guideline does not specify criteria for
a “defined geographical area,” it defines a transmission zone in
the same way as the APOC framework. The 2016 Guideline
Development Group recommended that decisions about
interruption of parasite transmission, stopping MDA, and
confirmation of transmission interruption at the end of the
post-treatment surveillance period should be based on a
prevalence of infective parous flies of <0.1%. Statistical
confidence for this elimination threshold requires that a
minimum of 6,000 flies collected from “a transmission zone”
should be tested. The guideline does not address delineation of
a transmission zone and hence the geographical range over
which those flies are to be collected. To date, no validated
methodology for transmission zone delineation is available. We
review evidence here that population genetic measures of the
parasite (and its vectors) capture the history of transmission and
hence can be used as a proxy for defining transmission
zone boundaries.
Lymphatic Filariasis
LF is a vector-borne disease caused by three species of parasites:
Wuchereria bancrofti, Brugia malayi, and Brugia timori. The
majority of infections are due to W. bancrofti, which is found
throughout the tropics (Figure 2). Chronic infection with these
parasites can disrupt lymphatic function and lead to long-term
disability due to lymphedema (most commonly swollen lower
limbs) and scrotal hydrocele (Taylor et al., 2010; World Health
Organzation, 2011). Globally, ~68 million are infected with LF,
with 36 million microfilaremic persons, 19 million hydrocele
cases, and 17 million lymphedema cases (Ramaiah and Ottesen,
2014). In 1997, following a World Health Assembly resolution,
the WHO initiated elimination of LF as a public health problem,
using a two-pillar program of annual MDA to reduce
microfilaremia to levels that would not sustain continued
transmission, and management of morbidity and disability by
providing a minimum package of care (Ichimori et al., 2014).
Infective larval LF are transmitted to humans by mosquitoes
and migrate to the lymphatic system where they develop into
adult worms that live for ~4 to 6 years (Figure 1B). After mating,
female adult worms produce thousands of microfilariae
throughout their life, which circulate in the peripheral blood
and are available to infect mosquitoes during blood meals to
continue the transmission cycle. LF is transmitted by a wide
range of mosquito genera including Anopheles, Culex,Mansonia,
and Aedes (World Health Organization, 2013). In a striking
example of the power of adaptive evolutionary change, the daily
periodicity in density of microfilariae in peripheral blood is
tuned to the biting times of local vectors.
Human infections are diagnosed by detecting microfilariae on
blood films collected at the appropriate time of day, or by
detecting circulating filarial antibodies or antigens (Ag).
Detecting microfilariae on blood films requires technical skillFrontiers in Genetics | www.frontiersin.org 5and equipment and collecting blood at night (where vectors are
nocturnal) is challenging, so serology is usually used rather than
microscopy. The current standard test for programmatic
surveillance activities in W. bancrofti areas is a rapid diagnostic
test for circulating filarial antigens (World Health Organization,
2017b). Antibody tests are not usually used because antibodies
can persist for years after the death of adult worms. Both overall
and age-specific prevalence of LF infection (usually not peaking
until adulthood) is determined by transmission intensity, which
in turn depends on vector biting rates and the availability of
susceptible humans. The threshold for starting MDA programs is
microfilariae or antigen prevalence of ≥1% within an
implementation unit (IU), which is defined prior to mapping
(World Health Organization, 2011; World Health Organization,
2017b). The size of the IU was left to the judgment of the
endemic countries; some chose to map by village or district,
while others classified the entire country or regions. In areas in
Africa co-endemic for loiasis (L. loa filariasis), the use of antigen-
based test strips for mapping has probably overestimated LF
prevalence, because of false positives from people with high
intensity infection with L. loa (Wanji et al., 2015; Pion et al.,
2016). Thus, mapping should be revisited in loiasis co-endemic
areas using approaches that increase species specificity.
MDA is conducted annually with a single-dose combination
of albendazole with diethylcarbamazine (DEC) or, in
onchocerciasis co-endemic countries, with ivermectin.
Recently, the three drugs have been combined in some
countries (King et al., 2018), including those where elimination
targets have not been reached despite completing the required
rounds of two-drug MDA (World Health Organization, 2017a).
In loiasis co-endemic areas in Central Africa not meso- or
hyperendemic for onchocerciasis, biannual albendazole
treatment in combination with vector management is
recommended, since DEC and ivermectin can cause serious
adverse reactions in individuals with high L. loa microfilaremia
(Boussinesq et al., 2003; World Health Organization, 2012b).
The WHO recommendation is for MDA to be conducted
until large, well-designed transmission assessment surveys
(TASs) of 6- to 7-year-old children in schools or communities
determine that the estimated antigen prevalence in an evaluation
unit has dropped below a critical cutoff value, when transmission
is not considered sustainable (World Health Organization, 2011;
World Health Organization, 2017b). Critical cutoff values
depend on the filarial and vector species, and are calculated
such that the likelihood of an evaluation unit passing is at least
75% if true antigen prevalence is 0.5%, and no more than 5% if
the true antigen prevalence is 1% (World Health Organization,
2011; World Health Organization, 2017b). For example, in
regions where W. bancrofti is endemic and transmission is
dominated by Aedes spp. mosquitoes, the threshold is based on
an upper 95% confidence limit for antigen prevalence of 1%. The
TAS evaluation unit can be the same as the IU, it can be larger
and include several IUs, or it can be smaller (by splitting an IU),
depending on available information on likely residual LF
endemicity. Once a country has passed two post-MDA TASs at
2- to 3-year intervals in all evaluation units, it can apply forJanuary 2020 | Volume 10 | Article 1282
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validation surveillance also uses TAS in 6- to 7-year olds (World
Health Organization, 2017b). Morbidity management and
rehabilitation must continue as needed.
Delineating Transmission Zones for
Sustainable Onchocerciasis and LF
Elimination
Onchocerciasis
The mosaic of onchocerciasis hyper-, meso-, and hypoendemicity
in Africa implies an underlying geographic mosaic of parasite
transmission zones (Figure 3; African Programme for
Onchocerciasis Control/World Health Organization, 2010) that
is the product of long-term, historical spatial density and
migration patterns of the blackfly vector and of the human host
(Blouin et al., 1995; Nadler, 1995; Jarne and Théron, 2001;
Criscione and Blouin, 2004; Criscione et al., 2005; Prugnolle
et al., 2005; Barrett et al., 2008). This pattern was not important
for implementation of “project areas” for control of onchocerciasis
as a public health problem (i.e., morbidity reduction and
prevention), which were delineated based on the administrative
borders of health system units in which meso- and hyperendemic
areas were located. However, with the switch from control as a
public health burden to elimination of transmission, explicit
consideration should be given to the alignment of intervention
areas and the areas included in the evaluations for decisions to
stop treatment (subsequently referred to as “evaluation areas”)
with the true, long-term parasite transmission zones.
Although the success of MDAi has driven the move from
control to elimination of onchocerciasis, there are some areas in
Africa in which many years of MDAi have reduced infection
prevalence less than expected (i.e., less than transmission models
predict) or where resumption of transmission has been reported
following cessation of interventions (Kamga et al., 2016; Tekle
et al., 2016; Koala et al., 2017; Bakajika et al., 2018; Komlan et al.,
2018; Koala et al., 2019). Transmission models predict that the
duration of interventions required to interrupt transmission is
dependent on vector abundance (which determines the
percentage of the population infected before interventions
begin), and the treatment frequency and percentage of the
population taking ivermectin (African Programme for
Onchocerciasis Control/World Health Organization, 2010;
Stolk et al., 2015). Consequently, the apparent failure of MDAi
to interrupt transmission in some treatment areas, and of post-
treatment recrudescence in others, might be due to highly
hyperendemic areas requiring longer-than-assumed duration of
MDAi (and/or higher treatment coverage and/or more frequent
treatment; Stolk et al., 2015) or higher-than-appropriate
thresholds of vector infectivity for deciding to stop
interventions. An alternative explanation that has yet to be
modeled, or considered explicitly in any guideline, is that
continuing transmission/recrudescence may be a result of
continuing parasite invasion from neighboring areas; i.e., there
may be discordance between an intervention or evaluation area
and the parasite transmission zone within which the area is
located. In order to achieve sustainable elimination, transmissionFrontiers in Genetics | www.frontiersin.org 6must be interrupted in the whole transmission zone, which needs
to be effectively delineated to ensure that the whole zone is
included in both interventions and evaluations.
The risk of parasite invasion is illustrated by two reports from
river basins in Burkina Faso where transmission was considered to
have been permanently interrupted. In the Comoé basin,
retrospective analysis of recrudescence suggested that long-range
vector movement was responsible, although immigration of
infected people from outside the basin was not excluded.
Ongoing transmission was confirmed via entomological
assessments at 4/4 capture points (Koala et al., 2017; Koala et al.,
2019). The second Burkina Faso report investigated microfilariae-
positive individuals in the Upper Mouhoun, Nakambé, and
Nazinon river basins and found all but 1 of the 31 infected
individuals recently resided in neighboring Côte d’Ivoire
(Nikièma et al., 2018). The remaining person had been previously
identified as infected in2008 (Nikièma et al., 2018).Thus,migration
between an area with and an area without ongoing transmission
accounted for 30/31 of the identified infected people.
The two cases described above point to immigrant parasites as
the potential source of renewed transmission and emphasize the
importance of knowing whether or not new infections are due to
parasites which “immigrated” via vectors or humans for
determining areas to be included in appropriate treatment
strategies. Similarly, the estimated risk of immigration via
humans or vectors is important for elimination programs to
make cost–risk based decisions: i.e., evaluate the cost of stopping
MDAi based on the risk of resurgence due to immigration from
areas that do not yet meet stopping criteria versus the cost of
continuing MDAi until these other areas also meet stopping
criteria. Finally, such information can provide lessons for
evaluations required for decisions to stop interventions,
including delineation of evaluation areas, sampling criteria, or
thresholds for MDAi cessation, which are all currently
determined independent of vector abundance.
Lymphatic Filariasis
In 2012, 73 countries were regarded as LF endemic (Ramaiah and
Ottesen, 2014), with 55 implementing MDA. By October 2019,
15 countries had been validated as having eliminated LF as a
public health problem: Vanuatu, Tonga, Niue, Cook Islands,
Republic of the Marshall Islands, Palau, Wallis & Futuna,
Kiribati, Cambodia, and Vietnam in the WHO Western Pacific
Region (WPRO); Sri Lanka, Maldives, and Thailand in the WHO
South East Asian Region (SEARO); Egypt in the WHO Eastern
Mediterranean Region (EMRO); and Togo in the WHO African
Region (AFRO) (World Health Organization, 2019) (Figure 2).
While 15 countrieshave achievedvalidationof elimination so far
(and some are nearing this milestone), there are countries where
progress toward elimination has stagnated or reversed, including
several in the Pacific where LF is transmitted by efficient day-biting
Aedes vectors and where there may also be supplementary night-
biting vectors (Ichimori andGraves, 2017). These countries include
American Samoa, Samoa, French Polynesia, and Fiji.
LF is relatively heterogeneous in its distribution within
countries, and thus the role of movement betweenJanuary 2020 | Volume 10 | Article 1282
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transmission is a concern for many national LF elimination
programs. Transmission zones in W. bancrofti are highly
dependent on variation in vector density, survival, and
competence for transmission and whether vector mosquitoes
are diurnal, nocturnal, or sub-nocturnal. In areas with post-
intervention recrudescence, there are sometimes infection “hot
spots”: a localized area where prevalence is significantly higher
than surrounding areas (e.g., American Samoa: Lau et al., 2014;
Lau et al., 2016; Lau et al., 2017; Sri Lanka: Rao et al., 2014; Rao
et al., 2017; Rao et al., 2018). Potential explanations for
recrudescence include expansion of infections from hot spots
when mosquitoes take up and transmit parasites to
geographically nearby communities or when infectious people
visit other communities, slow but insidious increase in frequency
and intensity of transmission from widespread infections at low
prevalence that were not detected or were considered
(incorrectly) to be under the threshold for stopping MDA, or
migrants from other endemic regions continue to introduce new
parasites, if the evaluation unit is inappropriately small.
The role of population movement between countries and
regions within countries in maintaining or re-establishing
transmission is a concern for many national elimination
programs. Continued surveillance post-MDA has been
recommended by researchers when communities are in close
proximity to cross-border regions with ongoing transmission
(Ramaiah, 2013; Dorkenoo et al., 2018). The possibility that
highly mobile migrant workers from Myanmar introduced and
maintained LF transmission in Thailand, after effective MDA
throughout most of the latter country, resulted in additional
rounds of MDA in border communities and sparked
epidemiological research on the connectivity between
communities (Bhumiratana et al., 2010; Satimai et al., 2011;
Bhumiratana et al., 2013; Toothong et al., 2015; Dickson et al.,
2017). The influx of thousands of refugees from Haiti, where LF is
hyperendemic, to Brazil, where LF transmission has been reduced
and even eliminated in some states, has prompted screening and
treatment of recent immigrants to reduce risk of re-introduction
(Nunes et al., 2016; da Silva et al., 2017; Zuchi et al., 2017). Even in
the remote islands of Samoa and American Samoa, models have
shown that movement of people between countries could have a
significant impact on the transmission of infectious diseases,
including LF (Xu et al., 2018b). The role of movement of infected
persons in the establishment and persistence of hot spots, and thus
the appropriate choice of the size for implementation and
evaluation units (both in terms of geographic size and total
population) for LF programmatic activities needs to be critically
evaluated for their impact on eliminationprogress. In contrast, long
distance vector dispersal is not typically considered amajor risk for
increasing the distribution or prevalence of the LF parasite
(Hapairai et al., 2013; Verdonschot and Besse-Lototskaya, 2014,
but see Huestis et al., 2019).
Crucial questions to be addressed for sustainable LF elimination
are thus: (1) what drives development of hot spots, and their
persistence after MDA, (2) what are effective methods for post-
MDA surveillance, when very low infection prevalence becomesFrontiers in Genetics | www.frontiersin.org 7difficult to detect, (3) how to determine appropriate target thresholds
for successful interruption of transmission in different settings (e.g.,
areas with different mosquito vectors), (4) what strategies should be
used to delineate intervention/evaluation units, (5) what role does
travel/migration(i.e., populationmovementandconnectedness)play
in the transmission of parasites between countries and between
regions within countries, and (6) how do transmission dynamics
among regions affect planning for future MDA? To stop
interventions and enter the “post-MDA surveillance” phase in a
specific geographic area requires reasonable certainty that the
probability of importation of parasites is too low to re-initiate
transmission, i.e., that stopping criteria are met across the whole
transmission zone. In other words, stopping MDA for LF also
requires delineation of transmission zone boundaries.PARASITE POPULATION GENETICS AND
TRANSMISSION ZONES
Filarial nematodes have nuclear genomes on the order of ~90–100
Mbp,mitochondrial genomes of ~13–14Kbp, andmost, but not all,
species obligately carry aWolbachia endosymbiont that has its own
genomeof~1Mbp (Keddie et al., 1998;Keddie et al., 1999;Unnasch
andWilliams, 2000; Foster et al., 2005;McNulty et al., 2012;Ramesh
et al., 2012; Desjardin et al., 2013; Cotton et al., 2016; Small et al.,
2016; Chung et al., 2017). Sequencing, assembling, and annotating
all three genomes for many helminth species, including the filariae,
is the objective of continuing efforts, and the availability and
assembly quality of parasite genomes will likely continue to
increase rapidly. Currently, the O. volvulus genome has the
highest quality assembly, with complete assemblies of
mitochondrial and Wolbachia genomes and nuclear genome
sequence scaffolds that are approaching whole chromosomes.
Genome resources for this and other parasites can be found at
https://parasite.wormbase.org/index.html.
With a few notable exceptions (Choi et al., 2016; Small et al.,
2016; Doyle et al., 2017; Small et al., 2019), most genomic research
for filarial nematodes has focused on predictions of gene function.
The aim of many of these “functional” predictions is to identify
targets fornewdrugdiscovery, usually in the absenceofmethods for
functional genomic validation of targets. Given the time formoving
from identification of potential drug targets to regulatory
registration and WHO guidelines for new drugs, it is unclear to
what extent drugs emerging from such research are going to be
available for use by LF and onchocerciasis elimination programs.
In contrast, relatively little attention has been paid to the
potential for the explosion of genomic information to support
elimination efforts with currently used drugs or new applications
of drugs such as moxidectin, which achieved regulatory
registration with the U.S. Food and Drug Administration in
2018 and is undergoing additional studies for inclusion in WHO
guidelines (Opoku et al., 2018). Understanding the geographic
distribution of variation in susceptibility to those drugs—
whether, for example, drug-naive populations already contain
alleles for reduced susceptibility—may allow us to act to preserve
susceptibility to those drugs. Population genomics analyzesJanuary 2020 | Volume 10 | Article 1282
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populations, identifying where that variation might impact
drug efficacy (the evolution of drug resistance) or elucidating
patterns of disease transmission (genetic epidemiology). We
review applications of population genomics to informing when
and where to cease treatment, on the quantifiable risk of
recrudescence through migration of infected humans/vectors
from other areas (O. volvulus Population Genetic Structure and
W. bancrofti Population Genetic Structure), and on the long-term
sustainability of MDA if poor response to drugs is heritable
(Parasite Population Genomics for Understanding Geographic
and Temporal Variability in Drug Response).
Conceptual Approach
Genetic structure is the result of movement of parasites within, but
not between, transmission zones: parasites within a transmission
zone interbreed and are genetically more similar to each other than
to parasites in another transmission zone, with whom they do not
interbreed. The likelihood that parasites are from the same
transmission zone, and thus likelihood of parasite transmission
between two locations (invasion), can therefore be inferred fromthe
degree of genetic relatedness between them (e.g., Blouin et al., 1995;
Nadler, 1995; Criscione and Blouin, 2004; Small et al., 2014).
Statistically significant genetic differentiation at neutral loci (i.e.,
loci which do not affect a phenotype subject to selection pressure)
between twoparasite samples indicates that theyoriginate from two
separate transmission zones (Figure 4). In contrast, high genetic
similarity among parasites indicates either historical or ongoing
gene flow (i.e., interbreeding), and that these more closely related
parasites are from a single transmission zone, regardless of
geographical scale. This genetic population structure—or lack of
it—is the result of long-term patterns of transmission. Measures of
population genetic structure could thus help programs assess the
risk of resurgence associated with alternative scenarios on a longer
time scale than intrinsically shorter-termdecisionsaboutwhere and
whom to treat. Population genetic measures have proven to be
informative for malaria epidemiology and control, particularly for
investigating sources of transmission or the origins and prevalence
of drug resistant strains (Jennison et al., 2015; Lo et al., 2017;
Aydemir et al., 2018; Fola et al., 2018; Waltmann et al., 2018).
In population genetic analyses, sequence data are collected
from parasites from multiple geographic locations. One
approach to analyzing these data is to compare and cluster
sequences based on the distribution of genetic variation across
a geographic area: members of the same parasite population
share similar patterns of genetic sequence variation because they
have been interbreeding (e.g., Pritchard et al., 2000; Jombart
et al., 2010). An alternative approach is to explore the history of
parasite movement by simulating the expected distribution of
genetic variation under different parasite migration histories, and
comparing test statistics derived from these simulated data to test
statistics calculated using the observed genetic variation (e.g.,
Laval and Excoffier, 2004; Peng and Kimmel, 2005).
Development of analytical methods suitable for quantitative
assessment of transmission of parasites within and among
geographic regions is an active area of research, and more in-Frontiers in Genetics | www.frontiersin.org 8depth reviews of these methods can be found elsewhere (e.g.,
Schawbl et al., 2017; Wesolowski et al., 2018).
Prior to MDA, filarial parasite populations had a widespread,
continuous distribution (e.g., onchocerciasis in Central/East
Africa; Figure 3). Because MDA (or vector control) reduces or
interrupts transmission, parasite population sizes fluctuate over
time, and their geographic distribution becomes increasingly
patchy. Parasite movement within a large geographic area in
which parasite populations were reduced to zero only in some
subareas can lead to transmission being re-established where it
was previously interrupted. These re-established parasite
populations and the parasite populations from which they
derive form what in ecology and population genetics is called a
“metapopulation” (Levins, 1969; Ariey et al., 2003; Churcher
et al., 2008; Tadiri et al., 2018). Where there is a pattern of re-
establ ishment post- intervention, parasites within a
metapopulation are genetically similar, and the geographic
range of this metapopulation defines the transmission zone.
Parasitic nematodes tend to have higher genetic diversity than
vertebrates (e.g., Blouin et al., 1992; Grant and Whitington, 1994;
Blouin et al., 1995; Hawdon et al., 2001; Prichard, 2001), possibly
due to their complex life cycles, transmission epidemiology
(Criscione et al., 2005), and large population size. Although the
high genetic diversity in parasitesmay require a large sample size to
ensure the data are representative, estimating population genetic
structure does not require a complete, assembled genome.
Researchers target genomic regions identified as sufficiently
informative to reveal relatedness among individuals. For example,
estimating genetic diversity and population structure using
mitochondrial sequence data is well established in population
genetics. The advantages of mitochondrial markers include that
they are maternally inherited, have a higher mutation rate than the
nuclear genome (10- to 17-fold; although this may be lower in
species associated withWolbachia; Cariou et al., 2017), have a high
copy number relative to the nuclear genome in each cell (useful for
DNA sequencing of samples with low concentration or degraded
DNA), and do not generally recombine. Mitochondrial genomes
upon which markers for population genetics can be built are also
widely available across filarial nematodes, including O. volvulus
(Keddie et al., 1998; Unnasch and Williams, 2000), W. bancrofti
(Ramesh et al., 2012; Small et al., 2016), B. malayi (Williams et al.,
2000), L. loa (Higazi et al., 2004), and the canine heartworm,
Dirofilaria immitis (Hu et al., 2003).
There are advantages to conducting population genetic
analyses that include nuclear markers: they are inherited from
both parents, and the extent of recombination between markers
can be informative about past demographic events such as
reductions in population size or selection on heritable traits
(both events cause markers to be linked: two or more DNA
variants on a chromosome become associated more often than
expected by chance). Nuclear variation has been estimated using
partial sequences of multi-copy ribosomal genes or spacers,
common repeat sequences, microsatellites, and fingerprinting
using electrophoresis of randomly amplified DNA (RAPD).
While these approaches have been useful due to their low cost
compared to whole-genome sequencing, ease of experimentalJanuary 2020 | Volume 10 | Article 1282
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(e.g., Blouin et al., 1995), capturing only a small part of genome
variation underestimates diversity and can result in estimates of
genetic variation with low information content (e.g., Keddie
et al., 1999; Higazi et al., 2004). Analyses that utilize whole-
genome sequencing data, rather than a few selected loci, can also
identify the confounding effects of selection on estimates of
population size, structure, and migration (see, e.g., Weigand
and Leese, 2018). Increasing the information available per
individual using whole-genome sequencing of either
individuals or pools of individuals, and increasing the
information available per population by increasing the total
number of individuals sequenced, has improved the sensitivityFrontiers in Genetics | www.frontiersin.org 9and power of analyses, and will improve our understanding of
disease transmission.
O. volvulus Population Genetic Structure
O. volvulus population genetic structure is determined by the
geographic range and movement of its hosts and vectors. The
major blackfly vectors in Africa belong to a species complex (S.
damnosum s.l.) divided into a number of subspecies based on
cytotaxonomy (Boakye, 1993; Boakye and Meredith, 1993;
Krueger and Hennings, 2006), although these subspecies are
not all distinguishable using DNA sequence data (Tang et al.,
1995; Tang et al., 1996). Variation in vector species distribution
could influence O. volvulus population structure, becauseFIGURE 4 | Alternate possibilities for distribution of genetic variation in parasites within a hypothetical country. (A) Haplotype frequencies (each unique sequence has
a different color) from three locations within one country where nematodes were collected, and from a second country (haplotypes in grey), indicate all three locations
are genetically distinct. The resulting haplotype network indicates sequence divergence between haplotypes. Taken together, these results would support the
conclusion that there are three transmission zones in which parasites persist. (B) Haplotype frequencies in three locations where nematodes were collected indicate
that they are genetically similar. The resulting haplotype network supports the conclusion that there is one transmission zone, and that recrudescence is local.
(C) Haplotype frequencies in three locations indicate that they are genetically similar. The haplotype network indicates that recrudescence may have come from a
migrant source, because haplotypes are shared between countries (1 and 2).January 2020 | Volume 10 | Article 1282
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differently. Specific vector–parasite associations have been
postulated (Duke, 1981; Basáñez et al., 2009). Blackflies from
forest areas transmit more infective larvae of O. volvulus than
flies prevalent in savannah areas (Cheke and Garms, 2013), and
onchocerciasis-associated ocular damage is more common in
savannah than in forest areas (Dadzie et al., 1990).
Because of this higher prevalence of onchocercal blindness in
savannah compared to forest communities, early population
genetics research focused on methods for differentiating
“blinding savannah” and “non-blinding forest” parasite
“strains.” Nuclear genome variation in the O-150 repeat family
differentiated O. volvulus collected from forest and savannah
communities in West Africa and Nigeria (Erttmann et al., 1987;
Erttmann et al., 1990; Zimmerman et al., 1992; Zimmerman
et al., 1994a; Ogunrinade et al., 1999), but not Uganda or Sudan
(Fischer et al., 1996; Higazi et al., 2001). DNA sequences derived
from a ribosomal internal transcribed spacer (ITS-2) could not
distinguish forest and savannah O. volvulus from West Africa
(Morales-Hojas et al., 2007). Analyses of nuclear genome
sequences quantified admixture between parasites collected
from different forest and savannah sites: parasites can have a
mix of ecotype-associated markers (Choi et al., 2016), indicating
that parasites from forest and savannah can and do interbreed
and their respective transmission zones overlap.
Reconstruction of mitochondrial genomes of a small number
of geographically diverse adult O. volvulus (Choi et al., 2016) has
pointed to greater genetic diversity than previously reported
(Zimmerman et al., 1994b; Keddie et al., 1999). Crawford et al.
(2019) analyzed whole mitochondrial genomes of ~150 parasites
fromWest Africa and demonstrated that O. volvulus populations
are extremely genetically diverse and that the historical
population size was likely very large. More importantly in theFrontiers in Genetics | www.frontiersin.org 10context of this review, a subset of mitochondrial markers could
distinguish O. volvulus sampled in Ghana from those sampled in
Mali or Côte d’Ivoire (via discriminant analysis of principal
components; Figure 5A). Nuclear sequence data differentiated
worms collected in Ghana from those collected in Cameroon,
indicating that current, ongoing interbreeding between parasites
from these two countries is unlikely. Therefore, they are from
different transmission zones (Doyle et al., 2017). At an even
larger geographic scale, admixture analysis of genetic sequence
data demonstrated that American parasite populations are
derived from African populations: competent vectors existed in
areas where infected people from Africa were forcibly brought to
work as slaves (Zimmerman et al., 1994b; Unnasch and
Williams, 2000; Choi et al., 2016).
Analysis of population structure over shorter distances within
a single ecotype has been conducted for parasites from different
river basins. Nuclear genetic differentiation was clear between
individual parasites from the Mbam and Nkam river basins in
Cameroon, suggesting no (or limited) parasite transmission
between them, and that, consequently, the Mbam and Nkam
river basins belong to two different transmission zones (Doyle
et al., 2017). In practical terms, this means that decisions to stop
treatment in one basin may not need to take into consideration
ongoing transmission in the other. In contrast, both nuclear
(Doyle et al., 2017) and mitochondrial genomes showed little
genetic differentiation among parasites from three river basins
across an east-west transect of ~250 km in Ghana: the Daka river
basin on the eastern side of Lake Volta, the Pru river basin on the
western side, and the Black Volta/Tombe river basin to the north
(Figure 5B; Crawford et al., 2019). These results are consistent
with weak population structure between the three basins, and
significant past or current gene flow between them. The
epidemiological interpretation of this population structure isFIGURE 5 | Analyses of mitochondrial sequence data from West Africa. (A) Discriminant analysis of principal components (DAPC; Jombart et al., 2010) indicates
that Ghana is distinct from Côte d’Ivoire and Mali. (B) DAPC indicates that three river basins within Ghana should be considered a single transmission zone. BVT,
Black Volta/Tombe. From Crawford et al. (2019).January 2020 | Volume 10 | Article 1282
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amongst these three river basins (Crawford et al., 2019). The
Black Volta/Tombe, Pru, and Daka river basins should thus be
considered a single transmission zone: cessation of treatment at
any one location would require interruption of transmission
throughout the zone to reduce risk of recrudescence.
The analyses of mitochondrial and nuclear variation
presented here suggest that O. volvulus populations—and thus
transmission zones—can cover large regions and different river
basins. It remains to be seen to what extent these genetic
estimates of transmission zones can be correlated with wind-
facilitated vector movement, features of the local climate or
landscape that impact fly prevalence because of breeding site
availability, differences in transmission capacity of the local fly
vector species, or factors impacting movement among regions by
people such as low habitability, large distances, or seasonal
migration of workers.
W. bancrofti Population Genetic Structure
Within populations of W. bancrofti, genetic diversity (i.e., the
number of polymorphic sites, regardless of genetic background)
and haplotype diversity (i.e., the number of unique, contiguous
sequences) appear to be comparable to O. volvulus (de Souza
et al., 2014; Choi et al., 2016; Small et al., 2016; Doyle et al., 2017;
Crawford et al., 2019; Small et al., 2019). Diversity may be higher
where transmission rates are higher (Blouin et al., 1992; Blouin
et al., 1995), because population sizes are expected to be larger
where there is more active transmission, and larger population
sizes result in greater retention of genetic diversity over time.
Studies in Papua New Guinea (PNG; Small et al., 2013), Ghana
(de Souza et al., 2014), and India (Thangadurai et al., 2006; Hoti
et al., 2008b; Mahakalkar et al., 2017) have found high levels of
genetic variation among and within W. bancrofti populations,
and suggested higher similarities between geographically
proximate villages. Consistent with expectations that higher
transmission rates (and consequently, larger parasite
population size) may increase genetic diversity, Hoti et al.
(2008b) detected the highest genetic variability in densely
populated, urban areas.
Genetic differentiation has been associated with geographic
distance and other barriers to movement of people and vectors in
Ghana (de Souza et al., 2014), India (Kumar et al., 2002;
Thangadurai et al., 2006; Hoti et al., 2007; Patra et al., 2007),
and Nepal (Adhikari et al., 2015). For example, genetic
fingerprinting detected divergence among strains on either side
of the Western Ghats mountain range in India, likely driven by
the geographic barrier (Thangadurai et al., 2006). Genetic
differentiation between parasites from different vectors was
identified in the Andaman and Nicobar Islands (Dhamodharan
et al., 2008), and a nocturnally sub-periodic strain from Thailand
was genetically distinguishable from a nocturnally periodic
Myanmar strain (Nuchprayoon et al., 2007). These genetic
differences could be driven by geographic distance reducing
gene flow or a consequence of divergent phenotypic adaptation
to enhance transmission by different vectors. A significant
challenge with these studies is that many of them used RAPD
assays, yielding data which are difficult to compare betweenFrontiers in Genetics | www.frontiersin.org 11studies and have uncertain reproducibility (Penner et al., 1993;
Davin-Regli et al., 1995; Pérez et al., 1998).
Genomic sequencing of W. bancrofti within populations has
been limited to 20 individual worms from PNG (Small et al., 2016;
Small et al., 2019) and 27 from three geographically widespread
communities (Haiti, Mali, and Kenya; Small et al., 2019). Small
et al. (2019) analyzed all 47 genomes and found genetic
differentiation among all countries sampled, suggesting
migration is low or non-existent at this spatial scale. Further
analyses supported ancestral movement of parasites between
Africa and Haiti, likely driven by the forced imprisonment and
transport of people from Western and Central Africa to the
Americas (Small et al., 2019). These efforts indicate sufficient
genetic variation in W. bancrofti to detect gene flow. Advances
in whole-genome sequencing of W. bancrofti, such as those made
by Small et al. (2016; 2019), using either infective larvae dissected
from laboratory-reared mosquitoes or using selective whole-
genome amplification of single microfilaria isolated from blood
samples, may increase the feasibility and accuracy of using
molecular sequence data to identify and track transmission of
LF. In particular, advances in laboratory methods that could enable
sequencing from materials commonly collected during TASs (e.g.,
from rapid diagnostic tests: Rao et al., 2006; microfilariae slides:
Bisht et al., 2006; and dried blood spots: Kumar et al., 2019), would
in turn increase availability of sequence data in terms of the
number of individual parasites per community and the number
of communities, allowing accurate delineation of transmission
zones and identification of immigrant parasites.PARASITE POPULATION GENOMICS FOR
UNDERSTANDING GEOGRAPHIC AND
TEMPORAL VARIABILITY IN DRUG
RESPONSE
Conceptual Approach
One aim of population genomics is to identify genome variation
associated with phenotypic variation in traits of interest. Because
neither O. volvulus nor W. bancrofti can be cultured in the
laboratory, this work requires correlations to be determined from
worms collected from infected people and phenotyped for a trait
(e.g., disease manifestation, variation in drug response) and then
subsequently genotyped. For example, onchocerciasis disease
severity and manifestations vary widely across Africa, with
onchocerciasis-associated blindness more common in savannah
regions (Remme et al., 1989; Dadzie et al., 1990), and severe
onchodermatitis (Sowda, hyperreactive onchocerciasis)
prevalent in Yemen and in one focus in Sudan (Mukhtar et al.,
1998), but rare in other endemic areas (Al-Kubati et al., 2018).
Similarly, the extent to which the level of skin microfilariae
decreases after ivermectin treatment and the timing and extent of
subsequent increases in skin microfilariae levels varies between
individuals even in ivermectin-naive areas (Awadzi et al., 2014;
Opoku et al., 2018).
The challenge is determining whether there is a correlation
between a well-identified phenotype (e.g., early resumption ofJanuary 2020 | Volume 10 | Article 1282
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genotype (Figure 6). Identifying parasite population structure is
a critical first step: it allows identification of genetic similarities
and differences that arise because of degrees of relatedness
between worms (interbreeding) and not because of genetic
association with the parasites’ phenotype. Such genetic variants
should be excluded from analyses of correlations between
phenotypic and genotypic variation. Equally important, and
perhaps more challenging, is that the phenotype needs to be
well defined. For example, when comparing differences in
pathology, manifestations might depend on whether the person
was infected as a child or as an adult, on variation in the
longevity of microfilariae or adult worms in different
geographic regions (e.g., forest and savannah worms; see Duke,
1993), or on the genetic background of the human host driving
specific immunologic reactions (e.g., Sowda; see Hoerauf
et al., 2002).
Defining Phenotypic Variation in Drug
Response
The potential for the evolution of resistance to either macrocyclic
lactones (such as ivermectin) or benzimidazoles (such as
albendazole) in filarial nematodes infecting humans has been a
concern from the start of MDA programs (e.g., WHO Expert
Committee on Onchocerciasis Control 1993 and WHO, 1995),
because of demonstrated evolution of resistance in parasites of
domestic animals (Kaplan, 2004; Wolstenholme et al., 2004;
Wolstenholme et al., 2015). However, identifying drug
resistance in human-infecting filarial parasites that cannot be
cultured in the laboratory is challenging, and quantifying genetic
association with a phenotype is completely dependent on
identifying the correct phenotype.Frontiers in Genetics | www.frontiersin.org 12In O. volvulus, the phenomenon of “suboptimal response” to
ivermectin (SOR) was identified during research into reasons for
higher-than-expected prevalence of infection and skin
microfilariae levels in areas under long-term MDAi in Ghana.
SOR is defined as the resumption of microfilariae production by
adult female worms following ivermectin treatment earlier than
considered typical, resulting in detectable levels of skin
microfilariae 80–90 days post-treatment and the presence of
viable embryos and microfilariae in the uteri of female worms
obtained through nodulectomy (Awadzi et al., 2004a; Awadzi
et al., 2004b). Since reasons such as low ivermectin blood
concentrations were excluded, Awadzi et al. attributed SOR to
low susceptibility to the so-called “embryostatic” effect of
ivermectin, resulting in developmental stages of microfilariae
in the uteri 90 days after treatment (see also Grant, 1994). The
progeny of these worms would be available for transmission
earlier and for longer between rounds of MDAi than progeny of
susceptible worms releasing microfilariae later (Figure 6). If low
susceptibility to the “embryostatic” effect is heritable, the
prevalence of SOR parasites may increase over time. While
increasing prevalence of SOR worms is not expected to impact
effectiveness of MDAi for control of onchocerciasis as a public
health problem (because SOR does not change post-treatment
disappearance of microfi lar iae from the skin— the
“microfilaricidal effect”), it would negatively impact
elimination, which depends on progressively lower skin
microfilariae available for transmission. Since the initial
description of SOR, further investigations of SOR in Ghanaian
and Cameroonian areas with different ivermectin treatment
histories (e.g., Osei-Atweneboana et al., 2007; Osei-
Atweneboana et al., 2011; Pion et al., 2013; Nana-Djeunga
et al., 2014) have shown that SOR parasites are detectable evenFIGURE 6 | Impact of ivermectin on transmission when there is variation in worm response. (A) Pre-treatment phenotypic (colors) and genetic diversity within a
person is high. (B) When a person is treated with ivermectin, microfilariae are cleared from the skin and the uteri of the worms. (C) Post-treatment, some worms
begin reproducing earlier than others, giving them a transmission advantage (black phenotype). If this is a heritable trait, then a correlation between the phenotype
and genotype arises; in this case, between both the C at position 2 and the G at position 6 in the sequence.January 2020 | Volume 10 | Article 1282
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Modeling showed large inter-individual variability in skin
microfilariae repopulation rates among individuals from
Ghana, Liberia, Sierra Leone, and Guatemala treated one to
five times with ivermectin (Churcher et al., 2009). None of the
individuals from Ghanaian communities who received 10–19
rounds of ivermectin treatment (Osei-Atweneboana et al., 2007)
had a higher repopulation rate higher than the highest observed
in the control data set (skin microfilariae repopulation rate after
the first ivermectin treatment among individuals from Ghana,
Liberia, Sierra Leone, and Guatemala), but analysis by village
showed significantly higher repopulation rate for some villages
and for one previously untreated village in the same area
(Churcher et al., 2009) This supports the conclusion that SOR
parasites are present in ivermectin-naive communities and may
increase via selection by ivermectin treatment. Furthermore,
variability of response to ivermectin measured by skin
microfilariae levels over time after a single dose of ivermectin
was found among individuals from ivermectin-naive areas in
Ghana, Liberia, and the Democratic Republic of Congo: the skin
microfilariae kinetics in some of these individuals met the SOR
criteria used in other studies (Awadzi et al., 2004a; Awadzi et al.,
2004b; Opoku et al., 2018). It is unknown whether these
ivermectin-naive areas belong to the same transmission zones
as other nearby areas with ongoing MDAi. Together, these data
support the conclusion that O. volvulus populations consist of
worms with variable susceptibility to the embryostatic effect of
ivermectin. Based on these data, the phenotype for genomic
analysis is the reproductive status of individual female worms
collected from people 80–90 days post-ivermectin treatment:
female worms that respond well to ivermectin should not have
post-fertilization embryonic stages, while those considered SOR
have early resumption of fecundity, and thus already have
microfilariae in uteri (Osei-Atweneboana et al., 2011; Nana-
Djeunga et al., 2014; Doyle et al., 2017).
In W. bancrofti, reasons underlying continued persistence of
transmission are challenging to determine. So far persistence has
not yet been associated with heritable variability in parasite drug
response. Density-dependent effects on vector response to
infection and vector competence play a role in continuous,
low-level transmission, depending on the vector species: iL3
development is proportionally higher at lower microfilariae
densities in some vector species, while in other vectors, fewer
iL3 develop when many microfilariae are ingested (Pichon, 2002;
reviewed in Graves et al., 2016). These differences change
transmission dynamics during MDA in ways highly dependent
on specific vector species that may favor greater vector efficiency
when microfilaremia is low.
Defining Correlations Between Phenotypic
and Genotypic Variation for Drug
Response
Several point mutations in the target of albendazole, b-tubulin,
lead to drug resistance in nematodes (Kwa et al., 1994; Grant and
Mascord, 1996; Silvestre and Cabaret, 2002; Silvestre and
Humbert, 2002), and at least one of these has been identifiedFrontiers in Genetics | www.frontiersin.org 13in W. bancrofti (Schwab et al., 2005). Increases in alleles
associated with benzimidazole resistance have been detected
after MDA (Schwab et al., 2005), and modeling suggests that
further MDA treatments would lead to selection via an increase
in the frequency of these alleles (Schwab et al., 2006; Schwab
et al., 2007). However, analysis of natural variation in response to
benzimidazole anthelmintics in the free-living nematode
Caenorhabditis elegans has shown that many other loci
contribute to and modify variation at the b-tubulin locus in
this species (Hahnel et al., 2018), and it is clear from analysis on
benzimidazole resistance in veterinary helminths that b-tubulin–
mediated resistance is also subject to modification by as yet
unidentified loci (Doyle and Cotton, 2019).
With respect to DEC, this drug is not 100% effective against
LF (Eberhard et al., 1988; Eberhard et al., 1991), suggesting that
variation in DEC susceptibility exists and could lead to the
development and spread of drug resistance if poor
susceptibility is both heritable and mating and recombination
allow for assortment among alleles (Grant, 1994; McCarthy,
2005; Cobo, 2016).
The view that has emerged from single-candidate gene
association studies in helminths is that response to macrocyclic
lactones such as ivermectin (a glutamate-gated chloride channel
agonist) is a complex and highly variable phenotype, affected by
multiple genes across the genome (e.g., Dent et al., 2000; Ardelli
et al., 2009; Yan et al., 2012; Ardelli and Prichard, 2013; Menez
et al., 2016), with poor repeatability between studies, strains, and
species. A single-candidate gene approach has been applied to
ivermectin SOR in O. volvulus by sequencing genes that might
contribute to ivermectin resistance in other nematodes, and
comparing differences between communities that have never
received ivermectin and those that have, or between
microfilarial pools collected before and after treatment (Ardelli
and Prichard, 2004; Ardelli et al., 2005; Eng and Prichard, 2005;
Eng et al., 2006; Ardelli and Prichard, 2007; Osei-Atweneboana
et al., 2012). If a gene contributes to ivermectin response, the
expectation is that alleles that decrease sensitivity to ivermectin
would be more common in worms from areas that have had
many rounds of MDAi than in worms from ivermectin-naive
areas, or that they would be more common in microfilariae
collected shortly after ivermectin treatment than before
treatment, or would be more common in adult females that
have resumed reproduction within 80–90 days of treatment (the
SOR phenotype). Genes identified using this approach include b-
tubulin (Eng and Prichard, 2005; Bourguinat et al., 2006; Eng
et al., 2006; Bourguinat et al., 2007; Osei-Atweneboana et al.,
2012) and members of the ATP-binding cassette transporter
family (Ardelli and Prichard, 2004; Ardelli et al., 2005; Eng and
Prichard, 2005; Ardelli et al., 2006a; Ardelli et al., 2006b; Ardelli
and Prichard, 2007).
However, this approach faces one of the biggest challenges in
detecting selection: the frequency of an allele can increase or
decrease due to random chance rather than selection. In
particular, if a population decreases in size, as might be
expected as transmission decreases during successive rounds of
MDA, the chance that changes in allele frequencies are stochasticJanuary 2020 | Volume 10 | Article 1282
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decreases (e.g., Schistosoma mansoni: Coeli et al., 2013), but the
fate of individual alleles is unpredictable, and some may increase
due to genetic drift caused by population decline. Another
challenge is that, prior to treatment, parasite populations can
be quite large (i.e., they have a high effective population size;
Blouin et al., 1995; Blouin et al., 1999; Zhou et al., 2013;
Rodelsperger et al., 2014; Jan et al., 2016), which means they
have ample genetic variation, so genetic variation contributing to
a poor response phenotype may be present at different
frequencies and at different loci in different parasite
populations (e.g., Haemonchus contortus, Gilleard and
Redman, 2016). Furthermore, once MDA begins, mating and
recombination could create new combinations of alleles from
different genes, which may also decrease response to ivermectin.
In other words, good responders may be carriers of alleles that, in
the right genomic background, could contribute to poor response
in drug naive populations, and vice versa. Selection then acts on
“standing” genetic variation that was present in the population
before the selection pressure began. This mechanism for
selection has been called a “soft sweep” (e.g., Hermisson and
Pennings, 2005; Przeworski et al., 2005; Pritchard and Di Rienzo,
2010; Ferrer-Admetlla et al., 2014; see also Doyle et al., 2017) and
is notoriously difficult to detect because (1) each variant alone
could have a weak effect on phenotype, and thus difficult to
distinguish statistically from background noise (random
variation), and (2) many techniques for detecting selection rely
on correlated, linked variants being physically near to the
causative mutation, but in a soft sweep, this linkage is often
weak (Pennings and Hermisson, 2006). The technical and
conceptual weaknesses of candidate gene approaches
specifically in the context of anthelmintic response was
reviewed recently (Doyle and Cotton, 2019).
Genome-wide approaches are, therefore, required. Doyle et al.
(2017) examined femaleO. volvulusmacrofilariae from Ghana and
Cameroon that were “good responders” and “suboptimal
responders” to the embryostatic effect of ivermectin, determined
by the absence or presence of stretched microfilariae in the uteri.
Females were pooled by response phenotype, sequenced, and
genetic variants correlated with phenotype identified. Genetic
variants clustered in 31 quantitative trait loci (QTLs) with genes
for molecular pathways involved in neurotransmission,
development, and stress response. None of these QTLs contained
genes previously proposed by single candidate association studies.
In addition, some loci associated with SOR to ivermectin in worms
fromGhana were different from loci associated with SOR in worms
from Cameroon. They concluded that ivermectin response is a
polygenic, quantitative trait, subject to soft sweeps of pre-existing
QTLs, rather “hard selection” on rare, resistance-conferring
mutations. Since populations possess different standing variation,
selection may act on different loci in different populations (Doyle
et al., 2017). Genome-wide studies of veterinary nematodes
generally support the “soft sweep QTL” model for response to
macrocyclic lactones (Bourguinat et al., 2015; Redman et al., 2015;
Choi et al., 2017; Doyle et al., 2019), and likewise have not
identified any of the candidate genes described above.Frontiers in Genetics | www.frontiersin.org 14This “soft sweep QTL”model that has emerged from genome-
wide association studies of ivermectin response leads to the
following predictions for control and elimination of
human filariases:
(1) Substantial natural variation in ivermectin (and perhaps
benzimidazole or DEC) response may exist within and between
populations at the beginning of MDA. Therefore, in some
populations, MDA could reduce transmission more efficiently
than in others, ultimately leading to elimination success in
some populations but not others. Genetic markers that predict
drug response can first be defined (as has been done for D.
immitis in the USA; Bourguinat et al., 2015; Bourguinat et al.,
2017; Ballesteros et al., 2018) and then used to identify “at-risk”
populations in which the initial SOR allele frequency is high
enough to prevent elimination by MDA alone.
(2) Selection for increased SOR allele frequency will likely occur
via soft sweeps, making detection of underlying genetic
changes more challenging. That said, a small panel of SNP
alleles can predict treatment response in D. immitis (with the
caveat that the population structure of D. immitis in these
studies is not reported; Bourguinat et al., 2015; Bourguinat
et al., 2017; Ballesteros et al., 2018).
(3) Ivermectin response appears to be a highly complex pheno-
type, and changes in the molecular targets of ivermectin may
not be the cause of SOR. For example, selection could favor
worms with a faster rate of embryonic development, or
resumption of microfilariae production might be driven not
by female recovery from an embryostatic effect, but by
recovery of males and thus earlier insemination, or by
recovery of one or both sexes from an effect that impairs
mating. The possibility that the embryostatic effect of iver-
mectin is a male- rather than female-mediated phenomenon
has not been tested in O. volvulus or LF, but suppression of
embryogenesis in D. immitis appears to be due to effects of
macrocyclic lactones on the reproductive competency of male
and not female worms (Lok et al., 1995). This has implica-
tions for how the drug response phenotype should be defined.
(4) It is now clear that variation in drug response is heritable. If
SOR alleles are initially present and selected for, even in only
some communities undergoing MDAi, SOR could spread
throughout the whole transmission zone (including to
hypoendemic areas not initially included in MDAi). An
important secondary advantage to identifying transmission
zones, then, is that the potential risks and time frame of the
spread of a SOR genotype to connected communities could
be quantified.DEVELOPMENT OF POPULATION
GENOMICS–BASED TOOLS TO INFORM
ELIMINATION PROGRAM DECISIONS
A wide range of DNA-based molecular tools have been
developed for detecting the presence of parasites in vectors andJanuary 2020 | Volume 10 | Article 1282
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Zimmerman et al., 1993; Rao et al., 2006; Rodriguez-Pérez et al.,
2006; Hoti et al., 2008a; Gass et al., 2012; Alhassan et al., 2015;
Owusu et al., 2015; Lau et al., 2016). The addition of information
on transmission gained from genomic analyses of parasites/
vectors to data on prevalence and intensity could significantly
improve the basis for elimination program decisions on whether
to stop or continue interventions, determine causes for
recrudescence post-intervention and thus appropriate
subsequent interventions, and determine optimal post-
intervention surveillance frequencies commensurate with the
risk of resurgence based on a cost–risk evaluation.
Methods to obtain and analyze genome sequences require
training and equipment not available to many laboratories in
endemic countries. However, once the required basic genome
research has been done, fast and relatively inexpensive methods
can be developed suitable for use in at least one laboratory in an
endemic country, possibly supported by one or more
“reference laboratories.”
Tools for Defining Transmission Zones
and Identification of Migrants
The “genetic signatures” of an interbreeding parasite population
constitute markers that allow delineation of transmission zones
as “the natural ecological and epidemiological unit for
interventions” for onchocerciasis or the implementation and
evaluation units for LF. In conjunction with transmission
models that allow modeling the impact of immigrant parasites
on long-term infection prevalence, the size of these zones can
inform cost–risk analysis for stop-treatment decisions as well as
when and where to conduct entomological evaluations or TAS,
dependent on the risk of resurgence that programs are willing
to accept.
The advantage of DNA-based transmission zone markers is
that they can be designed to be highly specific. The first step is
identifying variant sites informative for population structure; i.e.,
are polymorphic and more common or fixed (and thus have
different frequency-based likelihoods) in genomes of parasites
from one area compared to another. For example, Crawford et al.
(2019) identified mitochondrial polymorphic sites that could
differentiate O. volvulus collected in Ghana from countries
farther west with high statistical likelihood. Once such variant
sites have been identified for specific geographic areas, parasite
genomes from other areas need to be analyzed to determine
whether the same variants are informative, or whether additional
sites are necessary to infer the extent of interbreeding. Once
analysis is completed for parasites from across their distribution,
a minimum set of polymorphic sites can be defined to predict the
transmission zone of origin for any given worm.
This process may sound daunting, but methodology
developed over the past years is efficient and amenable to
further optimization. Skin snips or infected/infective Simulium
or O. volvulus adults from many areas in Africa are available in
the ESPEN laboratory in Ouagadougou, national laboratories,
and research centers. LF parasites, primarily on slides of blood
films and in dried blood spots, are available from endemic areas
in national laboratories and research centers.Frontiers in Genetics | www.frontiersin.org 15Developing inexpensive methodologies for routine use in
each endemic country is the next challenge. High resolution
melt (HRM) analysis has been proposed as a species
identification tool for Onchocerca spp. collected from blackflies
(Doyle et al., 2016) and could potentially be extended as a
genotyping tool. The advantage to using vectors is that, in the
case of Simulium spp., vector collection is already an integral part
of the process for stop-treatment decisions, invasive sampling of
people would not be required, and (if sampling strategies are well
designed) vectors would include a representative sample of
parasites from many different human hosts.
Tools for Monitoring Drug Susceptibility
Ideally, control/elimination programs would have reference data
on pre-MDA/early-MDA variability of parasite drug response
and an easy-to-use, cost-effective, and non-invasive tool for
monitoring changes in response phenotype frequency.
Detecting changes while the frequency of poor responder
alleles is low would allow alternative control/elimination
strategies to be put in place (Grant, 2000) and enable evidence-
based decisions on monitoring strategies. Some moves toward
these ends have been initiated (e.g., Ardelli and Prichard, 2004;
Eng and Prichard, 2005; Bourguinat et al., 2006; Bourguinat
et al., 2008; Hoti et al., 2009) but have yet to result in practical
application. Research for methods development for monitoring
potential emergence of resistance to ivermectin in O. volvulus
were initiated by the UNDP/World Bank/WHO Special
Programme for Research and Training in Tropical Diseases
(TDR) and OCP in the early 1990s (WHO Expert Committee
of Onchocerciasis Control (1993) and WHO, 1995; UNDP/
World Bank/WHO Special Programme for Research &
Training in Tropical Diseases, 1997). TDR also initiated
characterization of parasite drug response variability before or
early during MDA (Walker et al., 2016; Halder et al., 2017),
research which continues with Wellcome Trust funding
leveraged with this initial TDR investment. Alternative
strategies for onchocerciasis elimination include increased
MDAi frequency, complementary vector control, test-and-treat
strategies , and new drugs (African Programme for
Onchocerciasis Control, 2015; Boussinesq et al., 2018; Verver
et al., 2018; Horstick and Runge-Ranzinger, 2018).
Currently, screening communities for O. volvulus with low
ivermectin susceptibility requires either collection of skin snips
before and after ivermectin treatment to determine skin
microfilariae levels, or post-treatment nodulectomies to
determine the reproductive status of individual female worms.
Genetic analysis of microfilariae collected via skin snips at a
single post-treatment time point, or larvae in vectors, could
significantly improve monitoring capacity. While the molecular
mechanisms that contribute to variation in drug response are of
significant interest, identifying anonymous genetic variants
associated with drug response phenotype is sufficient for
development of tools for monitoring, even while research into
the mechanisms is ongoing.
Genetic variation associated with ivermectin response in O.
volvulushas been identified inparasites fromGhana andCameroon
(Doyle et al., 2017). These results have not yet been validated withJanuary 2020 | Volume 10 | Article 1282
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associated genetic variants identified are shared across
populations from other areas in Africa is untested. Compared to
development of transmission zone markers, development of
ivermectin response markers is much more challenging, since
large numbers of parasites with known response phenotype from
different geographic areas are needed to identify, validate, and test
the predictive value of genetic variants associated with
response phenotype.
Identification of a panel of relatively few variants (e.g., < 50)
would pave the way for developing a simple PCR-based or loop-
mediated isothermal amplification (LAMP) surveillance tool foruse
with parasites in vectors or skin snips by endemic country
laboratories. This core set of variants would define the QTLs that
are both necessary and sufficient for SOR to develop inO. volvulus
andmay, therefore, shed light on the as yet unexplainedmechanism
by which ivermectin exerts its embryostatic effect.
MDA for W. bancrofti uses albendazole, alone or in
combination with DEC and/or ivermectin. A PCR-based assay
for one single nucleotide polymorphism that leads to resistance
to benzimidazoles has been developed, so that monitoring for
allele changes in treated communities can occur (Hoti et al.,
2009). However, while variation in response to drug therapies for
LF has been reported (e.g., Eberhard et al., 1988; Eberhard et al.,
1991), to date a clear definition of an LF SOR has not been
reported (Irvine et al., 2017). A clear, and preferably quantitative,
definition of poor response is an essential prerequisite for
development of response genetic markers in LF.
Models Incorporating Population Genetics
to Estimate Risk of Recrudescence From
Migration or Poor Drug Response
There is a long history of the use of onchocerciasis and LF
transmission models such as EPIONCHO and ONCHOSIM
(reviewed in Stolk et al., 2015; Basáñez et al., 2016) and EPIFIL,
LYMFASIM, and TRANSFIL (reviewed in Smith et al., 2017) to
inform control program decisions. These models differ in whether
they are deterministic or stochastic and whether they are
population- or individual-based, and can be parameterized to
match the characteristics of a particular community, including
endemicity, variation in biting rates, or treatment coverage, such
that effects of different treatment strategies on transmission can be
explored. However, these programs currently cannot model
movement of parasites from one geographic area to another (via
people or vectors), spatial heterogeneity of endemicity or
elimination program implementation, or transmission of
parasites with variable drug susceptibility. Thus, although these
models have been useful in estimating declines of parasite infection
prevalence and intensity over a control campaign, they do not
realistically model variation in parasite drug susceptibility, human/
vector movement among areas, or long-term population processes
that could impede reaching elimination thresholds or contribute to
medium- to long-term recrudescence after MDA discontinuation.
To address these limitations, TDR funded extension of
transmission models for preventive chemotherapy-controlled
diseases. Coffeng et al. (2017) incorporated evolution of changesFrontiers in Genetics | www.frontiersin.org 16in drug susceptibility in O. volvulus (and other parasites) into a
stochastic, individual-based model, and McCulloch et al. (2017)
adapted an infection-intensity model, EPIONCHO, into a patch
framework for onchocerciasis, incorporating differences in
endemicity and treatment between two adjacent geographic areas,
or “patches,” and people and vector migration between patches.
When simulatingmigrationof seasonalworkers fromapatchwhere
transmission is ongoing to a patch where MDAi had interrupted
transmission, modest levels of migration (10% of the adult
population move for between 1 and 12 months) were sufficient to
re-establish transmission with a lag time of 5–10 years, and pre-
MDA prevalence was reached within 30–50 years in the absence of
renewed MDA.
Data from Burkina Faso showed a significant delay between
cessation of interventions and recrudescence (Koala et al., 2017;
Koala et al., 2019), suggesting that the predicted time frames for
recrudescence modeled by McCulloch et al. (2017) are realistic.
Such delays are not unexpected considering that parasite
invasion may initiate transmission at a low level, and
transmission takes time to become detectable. A model
incorporating population genetic structure data, allowing
simulation of vector and human movement–mediated parasite
transmission between different geographic areas, could provide
estimates of the risk and time frame of resurgence in one area
where treatment cessation is planned while transmission is above
stop-treatment thresholds elsewhere. National programs could
obtain a measure of risk for stopping interventions given
migration and an estimated time frame for resurgence, decide
whether to intensify interventions in areas that are potential
source areas of invasion, and plan cost-effective, post-MDA
surveillance strategies.
A model parameterized for a specific region can be
informative for elimination programs by exploring how
variation in treatment coverage, changes in human
demographic and travel patterns, vector control and migration
patterns, or other factors will affect progress toward and post-
intervention sustainability of elimination within different areas
in a region. Such a spatially explicit, agent-based modeling
framework was developed to explore LF transmission in the
Samoan Islands (GEOFIL; Xu et al., 2018a). This type of model
incorporates detailed information about individuals within the
community and their connectivity, and simulates changes in
characteristics such as age, physical location, and infection status.
GEOFIL predicts spatial variation in LF infection prevalence
across American Samoa over space and time. The model can
contribute toward understanding transmission dynamics in
areas of high infection prevalence (hot spots) which can help
determine effective surveillance strategies for identifying hot
spots, and how best to manage them. Incorporation of
information from genomic analyses could enhance the utility
of such models for elimination decisions. An agent-based
framework does require significant data on individual people,
information not available for many (or most) communities, and
it will be valuable to see how lessons from a well-characterized
system can be applied more broadly to areas where LF has re-
emerged post-MDA.January 2020 | Volume 10 | Article 1282
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RECOMMENDATIONS
Population genomic analyses of O. volvulus and W. bancrofti
show high levels of genetic variation consistent with historically
large population sizes (> 105). Genetic variation is spatially
structured; parasite populations are genetically distinct,
indicating that they are not interbreeding. For O. volvulus,
genomic data from West Africa indicate that the geographic
areas across which parasites interbreed—transmission zones—
can cover hundreds of kilometers and extend beyond the
boundaries of a “river basin, or a major section of a river
basin” (African Programme for Onchocerciasis Control/World
Health Organization, 2010). This large-scale structure is reflected
in the pattern of onchocerciasis endemicity in Africa, with a
mosaic of hypo-, meso-, and hyperendemic areas (Figure 3). For
W. bancrofti, transmission zones are larger than expected based
on the focal nature of many mosquito vector populations,
consistent with the increasingly recognized role that movement
of infected people plays. In epidemiological terms, genetic data
indicate that significant transmission must have occurred (and
likely to still be occurring) over tens to hundreds of kilometers.
We propose that long-range transmission via infected people
and/or infective vectors has epidemiological significance for
elimination programs that it does not have for control programs.
The latter plan to continue treatment indefinitely, and
consequently, the effect of occasional or continual long-range
transmission, is suppressed by continuing MDA. In contrast,
elimination programs stop treatment once relevant criteria have
been met within a defined area, assuming transmission has been
interrupted permanently. Without MDA, occasional or low but
continual parasite transmission from outside an intervention area
may result in recrudescence. Population genetic analyses can
predict whether the potential for gene flow is epidemiologically
significant. Consequently, elimination programs need to define the
boundaries of the entire extended geographic area over which
parasite transmission occurs and continue treatment until
transmission is interrupted over the entire area. From an
operational perspective, population genomic statistics do not
differentiate between long-range transmission due to movement
of vectors and that due to movement of people, and are thus
informative independent of the cause of parasite migration.
What research and development are required to allow
elimination programs to take advantage of population genomics?
One clear need is gatheringmore (and better quality) sequence data
across a greater geographical range, based on improved methodsFrontiers in Genetics | www.frontiersin.org 17which allow sequencing from parasite material already available or
routinely collected (blackflies or skin snips for onchocerciasis, and
mosquitoes or blood samples for LF). Testing and development of
analytical methods for quantifying parasite migration based on
genetic, entomological, and epidemiological data, and their optimal
application to transmission zone delineation, is critical. Tools not
requiring specialized laboratory equipment must be developed for
use by national programs to include in MDA and stop-MDA
evaluations. These tools would allow investigation of the source of
infections/transmission identified during post-treatment
surveillance, facilitate monitoring for changes in the frequency of
parasites with SOR to MDA, and promote planning cost-effective
solutions. Comparable population genomic data for vectors would
be a useful adjunct to differentiate between vector and human
movement as sources of long-range transmission to inform
appropriate interventions. Current transmission models need to
be enhanced to allow modeling of areas with different endemicity,
treatment history, progress toward elimination, heritable drug
resistance, and parasite gene flow, to better estimate the risk and
time frame of recrudescence when treatment is to be stopped in
one area while transmission is continuing in another. Finally, the
research and development outputs can improve procedures and
criteria for cessation of treatment, including estimating
risks of recrudescence to inform cost–risk assessment-based stop-
treatment decisions and appropriate post-treatment
monitoring strategies.AUTHOR CONTRIBUTIONS
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